Showing results (111-120 of 121) with videos related to
Sort By:
Pageof 13
Nature Immunology|August 22, 2006
Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteriaYuki Kinjo, Emmanuel Tupin, Douglass Wu, et al.Plos One|September 24, 2014
A full-length Plasmodium falciparum recombinant circumsporozoite protein expressed by Pseudomonas fluorescens platform as a malaria vaccine candidateAmy R Noe, Diego Espinosa, Xiangming Li, et al.Frontiers in Immunology|December 5, 2022
In silico and in vitro arboviral MHC class I-restricted-epitope signatures reveal immunodominance and poor overlapping patternsÁgata Lopes-Ribeiro, Franklin Pereira Araujo, Patrícia de Melo Oliveira, et al.Oncoimmunology|September 14, 2016
TLR4-mediated immunomodulatory properties of the bacterial metalloprotease arazyme in preclinical tumor modelsFelipe V Pereira, Amanda C L Melo, Filipe M de Melo, et al.Nature Immunology|September 6, 2011
Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteriaYuki Kinjo, Petr Illarionov, José Luis Vela, et al.Frontiers in Immunology|October 3, 2022
The role of mucosal-associated invariant T cells in visceral leishmaniasisMarcela de Lima Moreira, Luana Oliveira Borges-Fernandes, Marcelo Antônio Pascoal-Xavier, et al.Plos One|September 26, 2014
Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cellsManjunatha M Venkataswamy, Tony W Ng, Shalu S Kharkwal, et al.Frontiers in Immunology|August 28, 2024
MR1 blockade drives differential impact on integrative signatures based on circuits of circulating immune cells and soluble mediators in visceral leishmaniasisLuana Oliveira Borges-Fernandes, Marcela de Lima Moreira, Victória Hellena Silva Pereira, et al.Science Translational Medicine|April 19, 2022
An antibody class with a common CDRH3 motif broadly neutralizes sarbecovirusesLihong Liu, Sho Iketani, Yicheng Guo, et al.Journal of Leukocyte Biology|May 5, 2026
Immune Landscape of COVID-19 recovery: Nucleocapsid as a major target of CD8+ T cell antiviral responses in convalescent HLA-A*2+ individuals from BrazilÁgata Lopes-Ribeiro, Geovane Marques-Ferreira, Franklin Pereira Araujo, et al.Pageof 13